However, it has been shown to target a wider range of proteins and kinases, including some key mitotic kinases, such as Mps1 or Aurora A for example [20], and is a de facto widely used agent that is suitable for disrupting various biological signalling processes, mainly in inflammation, neurodegeneration and cancer [32]. This evidence concerns the gene TTK and cancer.